Colorectal cancer is the third most common cancer worldwide, and early detection is vital for effective treatment. As a ...

Radiation oncologist Alexander Valdman conducts research at the Department of Oncology-Pathology at Karolinska Institutet. He ...

In 2012, at the age of 44, was diagnosed with stage 3c colon cancer. Since then, she has been an advocate for awareness on TikTok.

A bowel cancer survivor has shared the five signs and symptoms she ignored before being diagnosed with the life-threatening disease.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial Authors ... to ...

PhD Defense: Systemic and local treatment strategies for initially unresectable colorectal cancer liver-only metastases ...

Optimal stopping ages for colorectal cancer (CRC) screening depend on sex, comorbidity, and prior screening history, affecting cost-effectiveness and clinical outcomes. The MISCAN-Colon model ...

Cancer treatment access differs significantly between traditional Medicare and Medicare Advantage  (MA), according to new research from the University of Colorado Cancer Center.

Tiago Biachi, MD, PhD, highlighted the transformative role of personalized medicine in gastrointestinal (GI) cancer treatment through advances in next-generation sequencing and circulating tumor DNA, ...

Invikafusp alfa has gained FDA fast track designation for treating TMB-H metastatic colorectal cancer. Invikafusp alfa ...